EMPIRE STATE BUILDING, NEW YORK, NY
Reports First Quarter 2026 Financial Results and Recent Business Highlights
Annual Report to Security Holders
IN8bio Reports 2025 Results - Survival Improvements in Glioblastoma
Director Resignation - Alan S. Roemer Steps Down from Board
Kate Rochlin Appointed President of IN8bio, Inc. Effective February 4, 2026
IN8bio, Inc. Enters Securities Purchase Agreement for Common Stock
Other Events
Results of Operations and Financial Condition
Q1
FY 2025
Q3
Q2
Amended Annual Report
FY 2024
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
S-8 POS